What 30 mg of Saffron Was Studied For, and the Two Things It Did Not Move

Three randomized trials tested one branded extract at one dose. They agree on the outcome it moved, and on the two it left completely alone.

30 mg of Affron saffron extract sits close to the 28 mg tested in three randomized, double-blind, placebo-controlled trials, each running twelve weeks. What those trials moved was mood: depressive symptoms and psychological distress scores. What they did not move was hot flashes, and in the most recent trial, sleep disturbance itself. All three were funded by the ingredient's manufacturer, and the effect sizes are small to moderate.

We put that extract in our formula and we sell it, so we have a reason to overstate this. Which is why the two null results and the funding are in the paragraph above rather than at the bottom.

Key takeaways

• Two of the three trials enrolled women in the target age band, which is unusual here. Most menopause botanicals rest on trials that used a different extract, dose, or population from whatever is in the bottle.
• The outcome saffron moved is mood. Saffron did not beat placebo on hot flashes or night sweats, and any vasomotor claim built on saffron is built on nothing.
• One trial ran 22 mg and 28 mg side by side. The 28 mg arm separated from placebo. The 22 mg arm showed no effect at all. Six milligrams decided it.
• All three trials come from a single research program funded by the extract's manufacturer. That is not independent replication.
• The finished Angry Lady formula has not been studied as a formula. Every trial on this page tested one ingredient by itself.

The word on the front, with no number beside it

You are standing in the aisle holding the fourth mood product you have picked up this year. Saffron is on the front in a serif font, because saffron reads as the expensive one.

You turn the box over looking for milligrams and find none. The word sits inside a blend total, or it stands alone with nothing after it.

So you make the decision the label was built for. You buy it, take it for five weeks, feel roughly the same, and set it beside the others. The problem is no longer the symptoms. It is that you can no longer tell the difference between something that works and something that sounds like it.

What the three trials measured

2026, women aged 50 to 70. 86 women with low mood and poor sleep took 28 mg daily for twelve weeks. 48.8% reached a clinically meaningful improvement in depression scores against 25.6% on placebo, P=0.026. Sleep disturbance itself did not differ from placebo (P=0.786). (Lopresti and Smith, Frontiers in Nutrition, 2026;13:1838513)

2021, perimenopausal women. In 86 perimenopausal women, the psychological score of the Greene Climacteric Scale improved significantly more than placebo (P=0.032). Anxiety fell 33% and depression fell 32%. Read those two carefully: they are changes from each woman's own starting point inside the saffron group, not the margin over placebo. They are the softer numbers and they get quoted as though they were the harder ones. (Lopresti and Smith, Journal of Menopausal Medicine, 2021;27(2):66-78)

2025, 202 adults with low mood. 72.3% reached a clinically significant improvement against 54.3% on placebo, P=0.010, with a small-to-moderate effect size (Cohen's d = 0.39). This one enrolled adults aged 18 to 70 of both sexes, so it is supporting evidence rather than population-matched evidence. (Lopresti et al., The Journal of Nutrition, 2025;155(7):2300-2311)

The six milligrams that decided it

A 2017 randomized placebo-controlled trial ran two saffron doses side by side in 128 adults with low mood: 22 mg a day and 28 mg a day.

The 28 mg arm separated from placebo on total mood disturbance. The 22 mg arm showed no treatment effect at all. Same extract, same trial, same weeks, opposite results.

That is the entire case for printing the number. A 200 mg blend and a 320 mg blend are each compatible with 22 mg of something, or with 2 mg, and neither will tell you which.

How the trials line up against our label

The company that prints the number

Angry Lady publishes 9 clinically studied ingredients and dosages, and Affron saffron extract at 30 mg is the strongest line on that panel. It is the one ingredient where the extract, the dose, the population and the outcome all line up.

That is a claim about verifiability, not superiority. The finished formula has never been studied as a formula, and the reason we can write something this specific is that the number is printed where you can check it.

It is also the strongest of the nine rather than a description of all nine. Red maca at 1,000 mg is the one we cannot place: it sits inside the range where effects have been observed, from 300 mg of a concentrated extract in perimenopausal women up to gram-scale raw powder, but the herb equivalent depends on an extract ratio we have not published. Magnesium glycinate at 150 mg is elemental weight inside a studied range starting at 100 mg, and it carries no sleep claim from us.

Where this is not your best option

If hot flashes are your main complaint, skip this. Saffron did not beat placebo on vasomotor symptoms in the trial that measured them. The botanical evidence across this whole category is weak there, ours included. For moderate to severe hot flashes and night sweats, hormone therapy has an evidence base no supplement matches.

If mood is your only complaint, a single saffron capsule will likely serve you better and cost less. One variable, one bottle, easier to discuss with a clinician. Check that it names a standardized extract and prints a dose above 22 mg, because a lower number was tested and did nothing.

If independent replication matters to you more than population match, this evidence base does not have it yet. Three trials, one research program, one funder, one lead author across the set. That is the first thing a fact-checker will find.

If thyroid, iron, B12 and vitamin D have not been checked, check those first. All four produce symptoms that look like this and all four are one blood draw away.

See every ingredient and dose →

Frequently asked questions

What was 30 mg of saffron studied for?
Mood. In three randomized placebo-controlled trials of the same branded extract at 28 mg daily over twelve weeks, the outcome that improved against placebo was depressive symptoms and psychological distress. Angry Lady uses 30 mg of that same extract.

Does saffron help hot flashes?
Not on this evidence. The 2021 trial states in its own conclusion that saffron was not associated with greater improvement in vasomotor symptoms. We will not imply otherwise, and neither should anyone else.

Does saffron help sleep?
Partly, and the split matters. In the 2026 trial, sleep-related daytime impairment improved while sleep disturbance itself did not (P=0.786). Daytime function moved. The night did not.

Who funded these trials?
The manufacturer of the saffron extract, with company employees among the authors. We are telling you because it changes how much weight the result carries, and because you would find it anyway.

Is 30 mg better than 28 mg?
There is no evidence that it is. 30 mg is roughly 7% above the tested amount, which puts our capsule at the studied dose rather than above it. What matters is that it is not 22 mg.

How long before the research says anything would show?
All three trials ran twelve weeks and reported on the twelve-week change. Five weeks is where most women in this category stop, and that sits before the first comparison any of these studies ran.

Should I take saffron on its own instead?
If mood is your only complaint, probably yes. A single-ingredient capsule is cheaper and cleaner, and there is nothing dishonest in saying so on a page selling a nine-ingredient formula.

You were never bad at reading labels

You lost the thread here because the labels were built so the thread could not be held, and then the confusion got filed under something being wrong with you.

Six milligrams decided the result in one of these trials. The number was never a detail. It was the finding, and most of this category has stopped printing it.

You do not have to trust us on saffron. You have to be able to check us on saffron. That is a different relationship, and it is the only one worth having with a company selling you something.

Angry Lady publishes this article and sells the supplement described in it, which contains the saffron extract discussed above. All three saffron trials cited were funded by the ingredient's manufacturer, and that is stated in the body rather than buried here. Competitor label figures come from published labels and public regulatory records. Our editorial standards, including how we select sources and how to report an error, are available on request at support@getangrylady.com.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Results referenced are from clinical studies on individual ingredients at their studied dosages and may not reflect individual results.